Predictive Technology Group Inc (PRED)

[brooklyn137]

It will be new shares, I'm pretty sure of that. But will this acquisition open up a whole new market in spinal treatment with their stem cells, which I expect. If so, then the revenue from this new area will be accretive to earnings by more than the dilution. I expect that both sides saw the synergy. PRED got the expertise in spinal and disc disease plus the data from RMT's 13 clinics. RMT will get PRED's stem cell supply and the power of being with a bigger company. From the PR RMT seems to have 13 clinics which will be generating income so there is a good chance it is accretive. But you're right, we need more info which we should get if they plan to uplist. I suspect they will have to release that info, if not in the form 10, then soon after.